Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our MissionYuet Wai Kan
Yuet Wai Kan, MD, pioneered the use of DNA to diagnose human diseases. He was the first to use fetal DNA to diagnose sickle cell anemia and thalassemia, and he discovered DNA polymorphism, which is now extensively used for genetic analysis.
Dr. Kan received the William Dameshek Prize in 1979 and the Henry M. Stratton Medal in 1980 for his research, and he served as ASH president in 1990. Currently, Dr. Kan is the Louis K. Diamond Professor of Hematology at the University of California - San Francisco. He focuses his research on the use of gene and cell therapy to treat sickle cell anemia and thalassemia.